Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 13/20 | 0.40 |
| ▸ | CNR1 | P21554 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | GFER | P55789 | 1/20 | 0.34 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.34 |
| ▸ | ESR1 | P03372 | 2/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
| ▸ | UGCG | Q16739 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25515581 | 0.88 | CNR2 (0.42) | CNR2CNR1KDM4ELMNAMAPT | |
| SCHEMBL23801340 | 0.88 | CNR2 (0.42) | CNR2CNR1KDM4ELMNAMAPT | |
| SCHEMBL25515585 | 0.88 | CNR2 (0.42) | CNR2CNR1KDM4ELMNAMAPT | |
| SCHEMBL25515679 | 0.87 | CNR2 (0.40) | CNR2KDM4ELMNAMAPTHPGD | |
| SCHEMBL25519569 | 0.84 | CNR2 (0.38) | CNR2CNR1LMNAMAPTNPY5R | |
| SCHEMBL23801779 | 0.80 | CNR2 (0.47) | CNR2KDM4ELMNAMAPTHPGD | |
| SCHEMBL25515451 | 0.80 | CNR2 (0.47) | CNR2KDM4ELMNAMAPTHPGD | |
| SCHEMBL25517719 | 0.79 | CNR2 (0.38) | CNR2CNR1KDM4ELMNAMAPT | |
| SCHEMBL23802438 | 0.79 | CNR2 (0.46) | CNR2KDM4ELMNAMAPTHPGD | |
| SCHEMBL23801317 | 0.78 | CNR2 (0.39) | CNR2CNR1KDM4ELMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | CNR2 663/4885CNR1 878/4885KDM4E 1857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.